United States - Re-Export of Extracts of Glands for Therapeutic Use
Since 2014, United States Re-Export of Extracts of Glands for Therapeutic Use jumped by 9.1% year on year. In 2019, the country was number 1 comparing other countries in Re-Export of Extracts of Glands for Therapeutic Use with $266,511. Georgia, Saudi Arabia and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. United States recorded the best 5 years average growth at +9.1% per year, while Canada witnessed the worst performance at -77.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 266,511.00 |
| 2018 | 321,918.00 |
| 2017 | 113,076.00 |
| 2016 | 242,626.00 |
| 2015 | 548,579.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Extracts of Glands for Therapeutic Use?
| # | 6 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
266,511.00 | 2019 | -17.2 % | +9.1 % | View data |
| 2 |
#2
Georgia
|
73,777.45 | 2018 | NA | NA | View data |
| 3 |
#3
Saudi Arabia
|
5,556.53 | 2018 | -81.5 % | NA | View data |
| 4 |
#4
United Arab Emirates
|
5,186.18 | 2018 | NA | +3.4 % | View data |
| 5 |
#5
New Zealand
|
311.12 | 2018 | NA | -22.2 % | View data |